NUMEDICUS LIMITED

Dissolved London

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
N

NUMEDICUS LIMITED

Research and experimental development on biotechnology

Founded 8 Dec 2008 Dissolved London, United Kingdom 0 employees website.com
Research and experimental development on biotechnology
Accounts Due 31 Dec 2025 4 months overdue
Confirmation
Net assets £359K £27K 2023 year on year
Total assets £411K £63K 2023 year on year
Total Liabilities £52K £36K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Sfp Warehouse W 3 Western Gateway Royal Victoria Docks London E16 1BD

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for NUMEDICUS LIMITED (06768310), a dissolved company based in London, United Kingdom. Incorporated 8 Dec 2008. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Balance Sheet & P&L (2014–2023)

Cash in Bank

N/A

Net Assets

£359.34k

Increased by £26.98k (+8%)

Total Liabilities

£52.05k

Increased by £35.69k (+218%)

Turnover

N/A

Employees

N/A

Debt Ratio

13%

Increased by 8 (+160%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active
Status
David John CavallaDirectorBritishEngland678 Dec 2008Active

Shareholders

Shareholders (1)

David John Cavalla
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

David John Cavalla

British

Active
Notified 8 Dec 2016
Residence England
DOB September 1958
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Marina Corwen Mccutcheon

Ceased 1 Aug 2024

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Aug 2025GazetteGazette Dissolved Liquidation
30 May 2025InsolvencyLiquidation Voluntary Members Return Of Final Meeting
1 Apr 2025AddressChange Registered Office Address Company With Date Old Address New Address
3 Jan 2025InsolvencyLiquidation Voluntary Removal Of Liquidator By Court
12 Dec 2024InsolvencyLiquidation Voluntary Appointment Of Liquidator
30 Aug 2025 Gazette

Gazette Dissolved Liquidation

30 May 2025 Insolvency

Liquidation Voluntary Members Return Of Final Meeting

1 Apr 2025 Address

Change Registered Office Address Company With Date Old Address New Address

3 Jan 2025 Insolvency

Liquidation Voluntary Removal Of Liquidator By Court

12 Dec 2024 Insolvency

Liquidation Voluntary Appointment Of Liquidator

Recent Activity

Latest Activity

Gazette Dissolved Liquidation

7 months ago on 30 Aug 2025

Liquidation Voluntary Members Return Of Final Meeting

10 months ago on 30 May 2025

Change Registered Office Address Company With Date Old Address New Address

1 years ago on 1 Apr 2025

Liquidation Voluntary Removal Of Liquidator By Court

1 years ago on 3 Jan 2025

Liquidation Voluntary Appointment Of Liquidator

1 years ago on 12 Dec 2024